Forza Innovations Inc.

Forza Innovations Inc. engages in the health-tech wearable performance business. It offers WarmUp series product line, including J4 Sport, J4 X, and J4 Fitbelt, which are wearable back compression devices that could be used to relax, warmup, loosen, or relax stiff and sore muscles. The company was formerly known as Genesys Industries, Inc. and changed its name to Forza Innovations Inc. in June 2021. Forza Innovations Inc. was incorporated in 2014 and is based in San Diego, California.

Forza Innovations Inc. trades as FORZ on OTC. The company is classified in Healthcare / Medical - Devices and reports in USD.

The current profile places the business in Medical - Devices. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $114,596 of revenue and -$4.76M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Forza Innovations Inc. can be compared against peers such as Plant-Based Investment Corp., Quantum Medical Transport, Inc., E Med Future, Inc., Electromedical Technologies, Inc., Eastgate Biotech Corp., First Choice Healthcare Solutions, Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $252,183, beta of 0.83, and return on equity of +103.2%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

FORZ currently shows total debt of $1.81M and beta of 0.83. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.forzainnovates.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.